RARγ overexpression has been reported for good proportions of patients with cholangiocarcinoma, clear cell renal cell carcinoma, colorectal cancer, ovarian cancer, and pancreatic ductal adenocarcinoma. The gene discussed is RARG; the disease is pancreatic ductal adenocarcinoma.